kleantouch Hand Sanitizer recalled for methanol contamination
Valisa MFG LLC is recalling kleantouch Hand Sanitizer 8 FL OZ pump bottles nationwide because the product contains methanol and was marketed without FDA approval. Consumers should stop using the product immediately.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: This is an FDA Class I recall, which per the rubric criteria requires a minimum score of 4. Methanol in hand sanitizer products poses a serious and direct health hazard, and the unapproved drug status combined with a known toxic ingredient elevates this to Critical.
Plain-English summary
Valisa MFG LLC is recalling kleantouch Hand Sanitizer (ethyl alcohol 70%), sold in 8.0 FL OZ (236 ML) pump bottles, distributed nationwide in the USA. The product is identified by UPC 6 86162 99246 1. Affected lot numbers are 1260-1, 1260-2, 1260-3, and 1260-4, with expiration date 04/2022.
The product was marketed without an FDA-approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Additionally, the product contains methanol, which makes it an unapproved new drug under FDA regulations.
Consumers who have purchased this hand sanitizer should stop using it immediately and dispose of it safely. Anyone with questions about the recall should contact Valisa MFG LLC, located in Farmingdale, NY.
The recalled product
- Product
- kleantouch HAND SANITIZER (ethyl alcohol 70%), 8.0 FL OZ (236 ML), pump bottles, Distributed by: Valisa MFG, LLC, Farmingdale, NY, 11735, Made in USA, UPC 6 86162 99246 1
- Manufacturer
- Valisa MFG LLC
- Category
- Drug — Hand Sanitizer
- Hazard
- methanol-contamination
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 1260-1
- 1260-2
- 1260-3
- 1260-4. Exp. 04/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27